India's drug regulator on Thursday approved the launch of pre-filled injector pens of Eli Lilly's blockbuster weight-loss drug, Mounjaro, giving the company more options to compete with rival Novo ...

Lilly gains CDSCO approval to launch Mounjaro KwikPen in India, challenging Novo Nordisk’s Wegovy in obesity drug market.

Eli Lilly and Novo Nordisk intensify their weight-loss drug rivalry in India as rising demand and looming generics reshape a ...

Eli Lilly said on Thursday India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster ...

Eli Lilly and Company (NYSE:LLY – Get Free Report) was the target of some unusual options trading activity on Thursday. Traders acquired 57,514 call options on the company.

Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. Eli Lilly and Company (LLY) Is a Trending Stock: Facts to ...

A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap — but when it comes to invention, AstraZeneca, with its wealth of experimental ...

Eli Lilly and Company (LLY) is on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 115 hedge fund portfolios held LLY at the end of the fourth quarter which was 106 ...

Eli Lilly has enjoyed a successful run the past several quarters as the company's blockbuster GLP-1 weight-loss drug Wegovy gains steam in the obesity space.But Wall Street wiped out more than $90 ...

Growth stocks often don't come cheap, especially when their prospects look great, as is the case with Eli Lilly (LLY-2.74%).It is the most valuable healthcare company in the world, with a market ...

Eli Lilly and Company's orforglipron had good results in Type 2 diabetes trials, potentially becoming the first scalable oral obesity drug. Click for my LLY update.